Brief: Living Cell Technologies Says Bernie Tuch Will Continue As Interim CEO Until End Of Jan 2023
Oct 31 (Reuters) - Living Cell Technologies Ltd
LCT.AX :
* BERNIE TUCH WILL CONTINUE IN ROLE AS INTERIM CEO UNTIL END
OF
JANUARY 2023
Further company coverage: LCT.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsAlgorae Pharmaceuticals rises on Australian distribution deal with India's Umedica
Brief: Algorae Pharmaceuticals Executes Licence & Supply Agreement With Umedica
Australia's Algorae Pharmaceuticals gains on Peter MacCallum Cancer Centre partnership
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre
Brief: Algorae Pharmaceuticals Named Launch Partner In Sovereign Ai Infrastructure Initiative